DILACOR XR Drug Patent Profile

✉ Email this page to a colleague

When do Dilacor Xr patents expire, and when can generic versions of Dilacor Xr launch?

Dilacor Xr is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in DILACOR XR is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Dilacor Xr

A generic version of DILACOR XR was approved as diltiazem hydrochloride by TEVA on May 31^st, 1995.

Subscribe

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for DILACOR XR?
What are the global sales for DILACOR XR?
What is Average Wholesale Price for DILACOR XR?

Summary for DILACOR XR

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	32
Clinical Trials:	1
Patent Applications:	76
DailyMed Link:	DILACOR XR at DailyMed

Drug patent expirations by year for DILACOR XR

Recent Clinical Trials for DILACOR XR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Assiut University	Early Phase 1

See all DILACOR XR clinical trials

US Patents and Regulatory Information for DILACOR XR

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Allergan	DILACOR XR	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020092-001	May 29, 1992		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Allergan	DILACOR XR	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020092-002	May 29, 1992		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
Allergan	DILACOR XR	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020092-003	May 29, 1992		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for DILACOR XR

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Allergan	DILACOR XR	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020092-003	May 29, 1992	⤷ Subscribe	⤷ Subscribe
Allergan	DILACOR XR	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020092-001	May 29, 1992	⤷ Subscribe	⤷ Subscribe
Allergan	DILACOR XR	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020092-003	May 29, 1992	⤷ Subscribe	⤷ Subscribe
Allergan	DILACOR XR	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020092-002	May 29, 1992	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for DILACOR XR

See the table below for patents covering DILACOR XR around the world.

Subscribe to access the full database, or Subscribe
Country	Patent Number	Title	Estimated Expiration
Austria	135906		⤷ Subscribe
New Zealand	218596	SYSTEM FOR THE CONTROLLED RELEASE OF ACTIVE SUBSTANCES	⤷ Subscribe
Canada	1298479	SYSTEME POUR LA LIBERATION PROGRESSIVE DE SUBSTANCES ACTIVES (SYSTEM FOR THE CONTROLLED-RATE RELEASE OF ACTIVE SUBSTANCES)	⤷ Subscribe
European Patent Office	0432607	Comprimés à libération contrÔlée des substances actives (Tablets with controlled-rate release of active substances)	⤷ Subscribe
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for DILACOR XR

Recent Clinical Trials for DILACOR XR

Make Better Decisions: Try a trial or see plans & pricing